ArticleActa neuropathologica2025
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.
Abstract readLetter
In one paragraph
Article in Acta neuropathologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Felix E HinzDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Dennis FriedelDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Franziska M IppenClinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Andrey KorshunovDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Leonille SchweizerNeurological Institute (Edinger Institute), Goethe University, Frankfurt, Germany.
Daniel SchrimpfDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Kirsten GöbelDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Lukas S FriedrichDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Fuat K ArasDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Henri BogumilDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Rouzbeh BananDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Hildegard DohmenInstitute of Neuropathology, Justus-Liebig University Giessen, Giessen, Germany.
Till AckerInstitute of Neuropathology, Justus-Liebig University Giessen, Giessen, Germany.
Sebastian BrandnerInstitute of Neurology, University College London, London, UK.
Simone SchmidDepartment of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
David CapperDepartment of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Niklas GrasslDKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Henning B BoldtDepartment of Pathology, Odense University Hospital, Odense, Denmark.
Pieter WesselingDepartment of Pathology, Amsterdam University Medical Centers, Amsterdam and Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Sybren L N MaasDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Juan P Garces MartinezDepartment of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Christine StadelmannDepartment of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Guido ReifenbergerInstitute of Neuropathology, Partner Site Essen/Düsseldorf, Medical Faculty, and University Hospital Düsseldorf, German Cancer Consortium (DKTK), Heinrich Heine University, Düsseldorf, Germany.
Thomas StehleInstitute for Neuropathology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Alonso Barrantes-FreerUniversity of Leipzig Medical Center, Paul-Flechsig-Institute of Neuropathology, Leipzig, Germany.
Tareq A JuratliDepartment for Neurosurgery, TU Dresden University of Technology, Dresden, Germany.
Stefan PuschDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Daniel HaagDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
David E ReussDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Christel Herold-MendeDepartment of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
Sandro KriegDepartment of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
Wolfgang WickA Partnership Between DKFZ and University Hospital Heidelberg, National Center for Tumor Diseases (NCT), NCT Heidelberg, Heidelberg, Germany.
Nima EtminanDepartment of Neurosurgery, Heidelberg University, Mannheim, Germany.
Michael PlattenDKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
David T W JonesA Partnership Between DKFZ and University Hospital Heidelberg, National Center for Tumor Diseases (NCT), NCT Heidelberg, Heidelberg, Germany.
Felix SahmDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Andreas von DeimlingDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany.
Abigail K SuwalaDepartment of Neuropathology, Pathological Institute, Heidelberg University Hospital, Heidelberg, Germany. Abigail.Suwala@med.uni-heidelberg.de.
Funding
DFG SU 1548/1-1
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.